Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that it will issue financial Anavex Life Sciences (AVXL) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its AVXL Anavex Life Sciences Corp.: From IHUB, Fletch dadofmarcmax Saturday, 07/20/19 06:54:06 PM Re: None 0 Post # of 202644 - #5488571
Anavex Life Sciences Corp. Common Stock (AVXL) News ...
Data as of 2020-06-06 Market Cap: 228.793 Million: Shares Outstanding: 58.665 Million: Avg 30-day Volume: 599.623 Thousand: P/E Ratio: Dividend Yield: EPS-0.45 OTC Markets | AVXL Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. AVXL Interactive Stock Chart | Anavex Life Sciences Corp ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. AVXL Options Chain
AVXL: Anavex Life Sciences Corp - Zacks Investment Research
Company profile. Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain and various types of cancer. AVXL stock: Anavex Life Sciences Corp AVXL stock: Anavex Life Sciences Corp Current Rating. Sell. Previous Rating. Strong Sell. Our Strong Buys double the S&P500! Learn more. Company Statistics. Price. $3.90. Market Cap. 234.7M Sector. Health Care. Div. Growth - P/E - P/B. 9.67 P/S - Dividend % - P/CF. 30.5 P/FCF - Op. Cash Flow Home - AVLX Prior to AVLX, Danny was the CEO of Morris, a world-class production and integration company. Danny started his career honing his technology and leadership skills in the defense industry in the US and Israel where he developed, manufactured, and launched audio and video products and managed teams that exceeded 250 members. AVXL Stock Charts
AVXL: Message Board for Anavex Life Sciences Corp ...
Anavex Life Sciences Stock Chart - AVXL - InvestorsHub
AVXL Stock Message Board for Investors. Anavex Life Sciences Corp. Stock Price, News and Company Updates. Message Board Total Posts: 1037
AVXL 13F Hedge Fund and Asset Management Owners